Jubilant Pharma US
Manufacturing · Pennsylvania, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
790 Township Line Rd Ste 325, Yardley, P...Phone Number
(215) 550-2810Website
www.jubilantpharma.comRevenue
$200.4 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
3
1
1
1
1
About Jubilant Pharma US
Jubilant Pharma Limited is a global integrated pharmaceutical company offering a wide range of products and services to our customers across geographies. We organize our pharma business into three segments. Firstly, Specialty Pharmaceuticals comprising Radiopharmaceuticals (including Radiopharmacies) and Allergy Therapy Products. our CDMO segment, comprising Contract Manufacturing for Non-Oral Formulation and Active Pharmaceutical Ingredients.Explore more
Jubilant Pharma US Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Jubilant Pharma US your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Jubilant Pharma US recently announced quarterly report
Product Launch: Get notified when Jubilant Pharma US launches new products
Website visits: Recent activity has been detected on your website
Check if Jubilant Pharma US has recently received funding, and reach out quickly before it becomes old news!
Check out if Jubilant Pharma US is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Jubilant Pharma US had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Jubilant Pharma US has new funding data
Jubilant Pharma US, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Jubilant Pharma US
Recommended Actions
Find VP level buyers at Jubilant Pharma US
Find 2 more new buyers
Compare Similar Companies to Jubilant Pharma US
Compare insights from companies similar to Jubilant Pharma US, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Jubilant Pharma US
$200.4M
501-1,000
Private
-
1978
MV
Michael Von OhlenVice President & General Counsel
Company Profile Activity
Activity Insights
Jubilant Pharma US is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Jubilant Pharma US is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Jubilant Pharma US.
Jubilant Pharma US Tech Stack
A closer look at the technologies used by Jubilant Pharma US
Most Recent Scoops
Hiring Plans
Jubilant Pharma US has more open roles in Sales than it has had at any time in the past 6 months. Technologies mentioned include: Salesforce.
Hiring Plans
Event
Product Marketing, Events, Training, Sales, Logistics / Supply Chain, Pharmaceuticals, Clinical Operations, Field Marketing, Manufacturing Operations, Operations
Hiring Plans
Jubilant Pharma US has more open roles in Marketing than it has had at any time in the past 12 months. Technologies mentioned include: Microsoft Project, and Microsoft Word.
Hiring Plans
Hiring Plans
Jubilant Pharma US has more open roles in Engineering & Technical than it has had at any time in the past 12 months. Technologies mentioned include: SQL, PanelView, Proficy Smart Factory, and Microsoft SQL Server.
Hiring Plans
Hiring Plans
Hiring Plans
Jubilant Pharma US News & Media
Jubilant Pharma Plans Stake Sale in Sofie Biosciences Amid Merger Deal - Investing.com
Read Jubilant Pharma Plans Stake Sale in Sofie Biosciences Amid Merger Deal By Investing.comJubilant Pharma to sell entire stake in Sofie Biosciences for $139.43 million - CNBC TV18
Jubilant Pharmova’s wholly owned subsidiary had in November 2020 invested $25 million in Sofie Biosciences and currently holds 25.8% stake, the firm said in a filing on January 28.Jubilant Radiopharma and Cardiac Imaging, Inc. Announce Exclusive Partnership to Expand Access for Mobile Cardiac PET Offering
MONTREAL--(BUSINESS WIRE)--Jubilant DraxImage Inc., dba Jubilant Radiopharma, a wholly-owned subsidiary of Jubilant Pharma Limited, has entered into an exclusive partnership with Cardiac Imaging, Inc., of Oakbrook Terrace, Illinois, to provide a daily-leased rubidium solution to healthcare facilities interested in performing cardiac PET. Offering healthcare facilities with the option to either use a flexible daily-leased rubidium program or build a full time PET program will ultimately increaseJubilant Radiopharma Introduces RUBY Mobile Solutions™
MONTREAL--(BUSINESS WIRE)--Jubilant Radiopharma announces FDA clearance to use its RUBY Rubidium Elution System™ and RUBY-FILL® (Rubidium Rb82 generator) in mobile settings.
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Jubilant Pharma US
Sign Up For FreeTo access detailed company insights
Jubilant Pharma Limited is a global integrated pharmaceutical company offering a wide range of products and services to our customers across geographies. We organize our pharma business into three segments. Firstly, Specialty Pharmaceuticals comprising Radiopharmaceuticals (including Radiopharmacies) and Allergy Therapy Products. our CDMO segment,... Read More
